Marksans Pharma Ltd consolidated Q1FY23 profit up QoQ at Rs. 59.71 crores

Marksans Pharma Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 450.267 crores during the period ended June 30, 2022 as compared to Rs. 433.387 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 59.716 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 28.109 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 1.46 for the period ended June 30, 2022 as compared to Rs. 0.69 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 450.267 crs	₹433.387 crs	3.89%
Net Profit	₹59.716 crs	₹28.109 crs	112.44%
EPS	₹1.46	₹0.69	111.59%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 450.267 crores during the period ended June 30, 2022 as compared to Rs.354.846 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.59.716 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.61.846 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.1.46 for the period ended June 30, 2022 as compared to Rs.1.51 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 450.267 crs	₹354.846 crs	26.89%
Net Profit	₹59.716 crs	₹61.846 crs	-3.44%
EPS	₹1.46	₹1.51	-3.31%

Shares of Marksans Pharma Limited was last trading in BSE at Rs. 49.80 as compared to the previous close of Rs. 49.85. The total number of shares traded during the day was 112302 in over 795 trades.

The stock hit an intraday high of Rs. 50.15 and intraday low of 49.20. The net turnover during the day was Rs. 5598257.00.

Source : Equity Bulls

Keywords

MarksansPharma Q1FY23 ResultUpdate